HAVN Life Sciences Inc.
HAVN Life Sciences Inc. is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs and the development of natural health products and innovative therapies to support brain health. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, the company offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle. Learn more at: havnlife.com and follow us on Facebook, Twitter, Instagram and Youtube.
HAVN Life Sciences Inc. (HAVN)
le 10 novembre/November 2023
Effective immediately, HAVN Life Sciences Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario and British Columbia Securities Commissions.